Skip to main content
. 2017 Dec 18;189(50):E1543–E1550. doi: 10.1503/cmaj.170599

Table 1:

Baseline demographic and clinical characteristics

Characteristic Treatment group; no. (%) of participants
No probiotic
n = 494
Probiotic
n = 515
No gum
n = 330
Sorbitol gum
n = 337
Xylitol gum
n = 342
Age group
 Adults (≥ 15 yr) 381/482 (79.0) 408/504 (81.0) 265/325 (81.5) 268/334 (80.2) 256/327 (78.3)
 Children (3–15 yr) 101/482 (21.0) 96/504 (19.0) 60/325 (18.5) 66/334 (19.8) 71/327 (21.7)
No. of episodes of sore throat in 3 mo before study
 0 86/479 (18.0) 107/507 (21.1) 69/325 (21.2) 55/336 (16.4) 69/325 (21.2)
 1 117/479 (24.4) 124/507 (24.5) 93/325 (28.6) 78/336 (23.2) 70/325 (21.5)
 2 120/479 (25.1) 119/507 (23.5) 61/325 (18.8) 92/336 (27.4) 86/325 (26.5)
 ≥ 3 156/479 (32.6) 157/507 (31.0) 102/325 (31.4) 111/336 (33.0) 100/325 (30.8)
Past tonsillectomy 51/494 (10.3) 55/515 (10.7) 37/330 (11.2) 36/337 (10.7) 33/342 (9.6)
Ever smoked 176/473 (37.2) 186/490 (38.0) 113/316 (35.8) 130/329 (39.5) 119/318 (37.4)
Clinical signs and symptoms at first consultation
 Substantial pharyngeal inflammation 321/482 (66.6) 342/503 (68.0) 214/323 (66.2) 237/333 (71.2) 212/329 (64.4)
 Cough 258/486 (53.1) 274/505 (54.2) 185/326 (56.7) 167/335 (49.9) 180/330 (54.5)
 Temperature > 37.5°C 39/487 (8.0) 25/506 (4.9) 22/327 (6.7) 23/334 (6.9) 19/332 (5.7)
 Pus on tonsils 158/479 (33.0) 151/502 (30.1) 93/320 (29.1) 105/333 (31.5) 111/328 (33.8)
 Cervical nodes 260/471 (55.2) 292/494 (59.1) 168/316 (53.2) 200/329 (60.8) 184/320 (57.5)
Duration of illness > 7 d (before consultation) 107/481 (22.2) 109/505 (21.6) 73/323 (22.6) 73/333 (21.9) 70/330 (21.2)